Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities

New-generation vaccines, formulated with subunits or nucleic acids, are less immunogenic than classical vaccines formulated with live-attenuated or inactivated pathogens. This difference has led to an intensified search for additional potent vaccine adjuvants that meet safety and efficacy criteria a...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Dinamarca, Diego A., Salazar, Michelle L., Castillo, Byron N., Manubens, Augusto, Vasquez, Abel E., Salazar, Fabián, Becker, María Inés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414397/
https://www.ncbi.nlm.nih.gov/pubmed/36015297
http://dx.doi.org/10.3390/pharmaceutics14081671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414397/
https://www.ncbi.nlm.nih.gov/pubmed/36015297
http://dx.doi.org/10.3390/pharmaceutics14081671

Ejemplares similares